Akebia Therapeutics
We're focused on the development & commercialization of therapeutics for people living with kidney disease.
268 employees · est. 2007 · Cambridge, United States
Liminal BioSciences is the older company (2007 vs 1992); Akebia Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Akebia Therapeutics | Liminal BioSciences |
|---|---|---|
| Founded | ||
| Founded | 2007 | 1992 older |
| Headquarters | ||
| Headquarters | Cambridge, United States | Laval, Canada |
| Employees | ||
| Employees | 268 larger | 27 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Post Ipo Debt | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $442.50M | $164.28M |
| Funding Rounds | ||
| Funding Rounds | 8 | 8 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical Company, Therapeutics, Kidney Disease, Pharmaceutical Development, Commercialization, Medical Research, Drug Development, Cambridge, Massachusetts | Not tracked yet |
| Website | ||
| Website | akebia.com | liminalbiosciences.com |
About Akebia Therapeutics
Akebia Therapeutics is a biopharmaceutical company headquartered in Cambridge, Massachusetts that has been focusing on developing and commercializing therapeutics for individuals affected by kidney disease since its establishment in 2007. The company recently received a significant $37.00M Post-IPO...
About Liminal BioSciences
Liminal BioSciences is a development-stage biopharmaceutical company distinguished by its focus on novel small molecule therapeutics that target G protein-coupled receptor (GPCR) pathways. With an eye on creating best-in-class solutions, the company aims to address unmet needs in metabolic, inflamma...
We will tell you when either one moves
BounceWatch watches Akebia Therapeutics and Liminal BioSciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Akebia Therapeutics and Liminal BioSciences — by email.
Frequently Asked Questions
Compare Akebia Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Akebia Therapeutics on 9 Jun 2026, and Liminal BioSciences on 13 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
